Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Common epilepsy drug levetiracetam presents potential clot risk for patients taking blood thinners

Researchers from the University of Liverpool and the University of Zurich have identified a potential safety consideration involving levetiracetam, one of the world's most commonly prescribed antiseizure medications.

Common epilepsy drug levetiracetam presents potential clot risk for patients taking blood thinners

We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.

Read the original at medicalxpress.com →

More in Health & Medicine

Evonik Expands in Slovakia

Compared with the conventional synthesis of chemicals, fermentation-based processes can offer a more sustainable route to selected intermediates by reducing the need for organic solvents and…

  • Evonik begins biotechnology expansion at Slovak Fermas site.
  • EUR 80 million investment to boost capabilities and services.
  • 50 new jobs created, aligning with sustainability strategy.

More from Monday 14 September →